Showing 11-20 results of 20
Cancer
A Research Study of OBI-902 in Participants with Advanced Solid Tumors.
This study will evaluate the safety and tolerability of investigational drug OBI-902 in participants with advanced solid tumors. The study also aims to find...
Cancer
New study for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
This study will compare the medication Sonrotoclax plus an anti-CD20 antibody therapy versus Venetoclax plus Rituximab. Enrollment into the different study...
Cancer
New study for patients with HR+ HER2- advanced breast cancer
This is a double-blind, placebo-controlled study evaluating the efficacy and safety of Inavolisib + a CDK4/6 inhibitor and letrozole, versus placebo + a...
Cancer
New investigational drug for treatment of ovarian cancer
This study will test the safety and effectiveness of an investigational drug combined with an FDA approved dose of Bevacuzimab for ovarian cancer....
Cancer
Investigational drug for breast cancer patients with brain metastases
The purpose of this study is to evaluate the safety and effectiveness of investigational drug UTD1 in combination with approved capecitabine in the treatment...
Cancer
Investigational drug for HER2-mutated/overexpressed/amplified cancer
This study is testing whether an investigational drug will help people with advanced cancers with HER2 alterations.
Cancer
New investigational drug for treatment of Myelofibrosis
This study will evaluate the safety and effectiveness of Navetemadlin combined with an FDA approved dose of Ruxolitinib. The purpose of this Phase III study...
Cancer|Women's Health
Investigational drug for treatment of Triple-Negative Breast Cancer
The purpose of this study is to evaluate the safety and effectiveness of investigational drug MK2870 in combination with other approved anti-cancer...
Blood Disorders|Cancer
A study for patients with aggressive B-cell non-Hodgkin lymphoma.
This study will evaluate the safety and tolerability of investigational drug IMPT-314. It will also help to determine the recommended phase 2 dosing.
Blood Disorders|Cancer
Study for patients with refractory/relapsed acute myeloid leukemia (AML).
The purpose of this study is to determine the safety and tolerability of the investigational drug BP1002 in participants who have refractory/relapsed AML...